Results: 56
Steroid-Induced Ocular Hypertension in a Pediatric Patient with Acute Lymphoblastic Leukemia: A Case Report.
- Published in:
- Children, 2022, v. 9, n. 3, p. 440, doi. 10.3390/children9030440
- By:
- Publication type:
- Article
Pharmacological screening of aqueous extract of Sesbania grandiflora for anti-glaucomic activity in Rabbits.
- Published in:
- Indian Journal of Natural Products & Resources, 2019, v. 10, n. 1, p. 43
- By:
- Publication type:
- Article
Evaluation of the Use of Brinzolamide-Brimonidine Fixed Combination in Maximum Medical Therapy.
- Published in:
- Turkish Journal of Ophthalmology / Turk Oftalmoloji Dergisi, 2022, v. 52, n. 4, p. 262, doi. 10.4274/tjo.galenos.2021.25488
- By:
- Publication type:
- Article
Efficacy of Topical Brinzolamide Treatment in Posterior Microphthalmos-Related Macular Cystoid Lesions: A Case Series.
- Published in:
- Turkish Journal of Ophthalmology / Turk Oftalmoloji Dergisi, 2020, v. 50, n. 1, p. 44, doi. 10.4274/tjo.galenos.2019.40504
- By:
- Publication type:
- Article
Nanotechnology-Tailored Drops of Brinzolamide and Curcumin for Glaucoma: Combined Attribution of Neuroprotection and Improved Oculo-Antihypertensive Effect.
- Published in:
- Current Trends in Biotechnology & Pharmacy, 2023, v. 17, p. 31
- By:
- Publication type:
- Article
The effect of a brinzolamide/brimonidine fixed combination on optic nerve head blood flow in rabbits.
- Published in:
- PLoS ONE, 2023, v. 18, n. 12, p. 1, doi. 10.1371/journal.pone.0295122
- By:
- Publication type:
- Article
Improvement of corneal epithelial damage after switching from the concomitant use of brinzolamide and brimonidine to a brinzolamide/brimonidine fixed-dose combination.
- Published in:
- Japanese Journal of Ophthalmology, 2024, v. 68, n. 5, p. 556, doi. 10.1007/s10384-024-01088-w
- By:
- Publication type:
- Article
Intraocular pressure-lowering effects and safety of brimonidine/brinzolamide fixed combination after switching from other medications.
- Published in:
- Japanese Journal of Ophthalmology, 2022, v. 66, n. 5, p. 440, doi. 10.1007/s10384-022-00930-3
- By:
- Publication type:
- Article
Co-delivery of brinzolamide and miRNA-124 by biodegradable nanoparticles as a strategy for glaucoma therapy.
- Published in:
- Drug Delivery, 2020, v. 27, n. 1, p. 410, doi. 10.1080/10717544.2020.1731861
- By:
- Publication type:
- Article
Whiter and Greener RP-HPLC Method for Simultaneous Determination of Dorzolamide, Brinzolamide, and Timolol Using Isopropanol as a Sustainable Organic Solvent in the Mobile Phase.
- Published in:
- Separations (2297-8739), 2024, v. 11, n. 3, p. 83, doi. 10.3390/separations11030083
- By:
- Publication type:
- Article
Two Stability Indicating Chromatographic Methods: TLC Densitometric versus HPLC Method for the Simultaneous Determination of Brinzolamide and Timolol Maleate in Ophthalmic Formulation in the Presence of Probable Carcinogenic Oxidative Degradation Product of Timolol Maleate
- Published in:
- Separations (2297-8739), 2023, v. 10, n. 1, p. 37, doi. 10.3390/separations10010037
- By:
- Publication type:
- Article
Investigating the ocular toxicity potential and therapeutic efficiency of in situ gel nanoemulsion formulations of brinzolamide.
- Published in:
- Toxicology Research, 2020, v. 9, n. 4, p. 578, doi. 10.1093/toxres/tfaa066
- By:
- Publication type:
- Article
Concurrent Uveal and Vitreoretinal Lymphoma Masquerading as Anterior Uveitis.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Toxicity and Physiological Actions of Carbonic Anhydrase Inhibitors to Aedes aegypti and Drosophila melanogaster.
- Published in:
- Insects (2075-4450), 2017, v. 8, n. 1, p. 2, doi. 10.3390/insects8010002
- By:
- Publication type:
- Article
Daily Costs and Cost Effectiveness of Glaucoma Fixed Combinations in China.
- Published in:
- Journal of Ophthalmology, 2020, p. 1, doi. 10.1155/2020/2406783
- By:
- Publication type:
- Article
Identification of Possible Causative Agents in a Polymedicated Patient Presenting With Toxic Epidermal Necrolysis.
- Published in:
- Journal of Pharmacy Practice, 2021, v. 34, n. 6, p. 970, doi. 10.1177/0897190020934295
- By:
- Publication type:
- Article
İnfantil Nistagmus Sendromunda Topikal Brinzolamid Kullanımının Göz İçi Basıncı Üzerine Etkisi.
- Published in:
- MN Opthalmology / MN Oftalmoloji, 2022, v. 29, n. 3, p. 154
- By:
- Publication type:
- Article
Efficacy of brinzolamide in the initial management of acute primary angle closure: A randomized controlled trial.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 6, p. 792, doi. 10.1111/jcpt.13609
- By:
- Publication type:
- Article
Co-delivery of Brinzolamide and Timolol from Micelles-laden Contact Lenses: In vitro and In Vivo Evaluation.
- Published in:
- Pharmaceutical Research, 2024, v. 41, n. 3, p. 531, doi. 10.1007/s11095-024-03672-8
- By:
- Publication type:
- Article
Comparison of allergy prevalence using brinzolamide 1.0% / brimonidine 0.2% fixed combination with and without β-blocker in glaucoma patients: a retrospective cohort study.
- Published in:
- BMC Ophthalmology, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12886-024-03550-2
- By:
- Publication type:
- Article
The Efficacy, Safety, and Satisfaction Associated with Switching from Brinzolamide or Brimonidine to Brinzolamide/Brimonidine in Open-Angle Glaucoma Patients.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 12, p. 2057, doi. 10.3390/jpm12122057
- By:
- Publication type:
- Article
Additive Intraocular Pressure-Lowering Effects of Ripasudil with Glaucoma Therapeutic Agents in Rabbits and Monkeys.
- Published in:
- Journal of Ophthalmology, 2017, p. 1, doi. 10.1155/2017/7079645
- By:
- Publication type:
- Article
Ocular Distribution of Brimonidine and Brinzolamide after Topical Instillation of a 0.1% Brimonidine Tartrate and 1% Brinzolamide Fixed-Combination Ophthalmic Suspension: An Interventional Study.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 13, p. 4175, doi. 10.3390/jcm12134175
- By:
- Publication type:
- Article
The Efficacy, Safety and Satisfaction Associated with Switching from Brinzolamide 1% and Brimonidine 0.1% to a Fixed Combination of Brinzolamide 1% and Brimonidine 0.1% in Glaucoma Patients.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 22, p. 5228, doi. 10.3390/jcm10225228
- By:
- Publication type:
- Article
Sulfonamide inhibition studies of two β-carbonic anhydrases from the ascomycete fungus Sordaria macrospora, CAS1 and CAS2.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2018, v. 33, n. 1, p. 390, doi. 10.1080/14756366.2018.1425687
- By:
- Publication type:
- Article
Brinzolamide/Brimonidine Fixed Combination: Simplifying Glaucoma Treatment Regimens.
- Published in:
- Ophthalmology & Therapy, 2018, v. 7, n. 2, p. 397, doi. 10.1007/s40123-018-0150-x
- By:
- Publication type:
- Article
Evaluation of the effects on choroidal thickness of bimatoprost 0.03% versus a brinzolamide 1.0%/timolol maleate 0.5% fixed combination.
- Published in:
- Cutaneous & Ocular Toxicology, 2017, v. 36, n. 4, p. 397, doi. 10.1080/15569527.2017.1315128
- By:
- Publication type:
- Article
Effects of Topical Carbonic Anhydrase Inhibitors on the Olfactory Sense.
- Published in:
- Beyoglu Eye Journal, 2021, v. 6, n. 1, p. 19, doi. 10.14744/bej.2021.27676
- By:
- Publication type:
- Article
A comparative study on efficacy of fixed combination timolol/brinzolamide versus travoprost monotherapy in drug-naïve open-angle glaucoma patients.
- Published in:
- Therapeutic Advances in Ophthalmology, 2020, v. 12, p. 1, doi. 10.1177/2515841420909666
- By:
- Publication type:
- Article
Ocular microemulsion of brinzolamide: Formulation, physicochemical characterization, and in vitro irritation studies based on EpiOcular™ eye irritation assay.
- Published in:
- Pharmaceutical Development & Technology, 2021, v. 26, n. 7, p. 765, doi. 10.1080/10837450.2021.1944206
- By:
- Publication type:
- Article
Quantification of Carbonic Anhydrase Inhibitors and Metabolites in Urine and Hair of Patients and Their Relatives.
- Published in:
- Biology (2079-7737), 2022, v. 11, n. 10, p. N.PAG, doi. 10.3390/biology11101379
- By:
- Publication type:
- Article
Formulation Development and Evaluation of the Therapeutic Efficacy of Brinzolamide Containing Nanoemulsions.
- Published in:
- Iranian Journal of Pharmaceutical Research, 2017, v. 16, n. 3, p. 847
- By:
- Publication type:
- Article
Design, development, and characterization of brinzolamide and brimonidine tartrate nanoemulsion for ophthalmic drug delivery.
- Published in:
- Thai Journal of Pharmaceutical Sciences, 2022, v. 46, n. 4, p. 413
- By:
- Publication type:
- Article
Safety news.
- Published in:
- WHO Drug Information, 2016, v. 30, n. 4, p. 577
- Publication type:
- Article
Development of RP-HPLC Method for Simultaneous Determination of Brimonidine Tartrate and Brinzolamide by QbD Approach and Its Validation.
- Published in:
- Eurasian Journal of Analytical Chemistry, 2016, v. 11, n. 2, p. 63, doi. 10.12973/ejac.2016.122a
- By:
- Publication type:
- Article
Effect of topical brinzolamide on visual function and waveform in patients of infantile nystagmus syndrome: A randomized control trial.
- Published in:
- Indian Journal of Ophthalmology, 2024, v. 72, n. 7, p. 976, doi. 10.4103/IJO.IJO_1010_23
- By:
- Publication type:
- Article
Effect of prophylactic intraocular pressure-lowering medication (brinzolamide) on intraocular pressure after ranibizumab intravitreal injection: A case-control study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Brinzolamide/timolol versus dorzolamide/timolol fixed combinations: A hospital-based, prospective, randomized study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Comparative Analyses of Efficacy and Safety of Fixed Versus the Free Equivalent Combination of 1% Brinzolamide and 0.5% Timolol in Glaucoma Patients: A Prospective Observational Study.
- Published in:
- International Journal of Pharmaceutical Research (09752366), 2021, v. 13, n. 2, p. 1104, doi. 10.31838/ijpr/2021.13.02.188
- By:
- Publication type:
- Article
Stability-Indicating Rp-Hplc Method Development And Validation For Brimonidine Tartrate In Bulk And Ophthalmic Suspension.
- Published in:
- International Journal of Pharmaceutical Research (09752366), 2020, v. 12, n. 3, p. 3964, doi. 10.31838/ijpr/2020.12.03.520
- By:
- Publication type:
- Article
BRINZOLAMIDE-2-HYDROXYPROPYL BETA CYCLODEXTRIN COMPLEX LOADED CHITOSAN NANOGEL FOR OCULAR DRUG DELIVERY.
- Published in:
- International Journal of Pharmaceutical Research (09752366), 2019, v. 11, n. 2, p. 6, doi. 10.31838/ijpr/2019.11.02.002
- By:
- Publication type:
- Article
Ocular and systemic pharmacokinetics of brimonidine and brinzolamide after topical administration in rabbits: comparison between fixed-combination and single-drug formulations.
- Published in:
- Current Eye Research, 2021, v. 46, n. 3, p. 380, doi. 10.1080/02713683.2020.1800046
- By:
- Publication type:
- Article
Efficacy and safety assessment of preservative‐free latanoprost (T2345) versus Xalatan™ in ocular hypertensive or glaucomatous patients.
- Published in:
- Acta Ophthalmologica (1755375X), 2012, v. 90, p. 0, doi. 10.1111/j.1755-3768.2012.F030.x
- Publication type:
- Article
Prevention of ocular hypertension in patients receiving intra‐vitreal steroids.
- Published in:
- Acta Ophthalmologica (1755375X), 2012, v. 90, p. 0, doi. 10.1111/j.1755-3768.2012.4613.x
- By:
- Publication type:
- Article
Validation and Experimental Design Assisted Robustness Testing of RPLC Method for the Simultaneous Analysis of Brinzolamide and Brimonidine Tartrate in an Ophthalmic Dosage Form.
- Published in:
- Indian Journal of Pharmaceutical Sciences, 2016, v. 78, n. 5, p. 631, doi. 10.4172/pharmaceutical-sciences.1000162
- By:
- Publication type:
- Article
An Unexpected Cause of Symptomatic Bradycardia: Anti-glaucoma Eye Drops.
- Published in:
- Cyprus Journal of Medical Sciences, 2022, v. 7, n. 5, p. 698, doi. 10.4274/cjms.2021.2546
- By:
- Publication type:
- Article
Nanoliposome-Encapsulated Brinzolamide-hydropropyl-β-cyclodextrin Inclusion Complex: A Potential Therapeutic Ocular Drug-Delivery System.
- Published in:
- Frontiers in Pharmacology, 2018, p. 1, doi. 10.3389/fphar.2018.00091
- By:
- Publication type:
- Article
Efficacy and tolerability of brinzolamide/brimonidine suspension and prostaglandin analogs in patients previously treated with dorzolamide/timolol solution and prostaglandin analogs.
- Published in:
- Clinical Ophthalmology, 2016, v. 10, p. 583, doi. 10.2147/OPTH.S98607
- By:
- Publication type:
- Article
Brinzolamide 1%/timolol versus dorzolamide 2%/ timolol in the treatment of open-angle glaucoma or ocular hypertension: prospective randomized patient-preference study.
- Published in:
- Clinical Ophthalmology, 2015, v. 9, p. 2263, doi. 10.2147/OPTH.S88891
- By:
- Publication type:
- Article
Clinical effectiveness of brinzolamide 1%--brimonidine 0.2% fixed combination for primary open-angle glaucoma and ocular hypertension.
- Published in:
- Clinical Ophthalmology, 2015, v. 9, p. 2201, doi. 10.2147/OPTH.S72380
- By:
- Publication type:
- Article